Jump to section
To reinvent the pain relief journey.
77% employee growth in 12 months
Over 50 million, around 1 in 5, Americans suffer from chronic pain, with the majority reporting an increase in their symptoms in recent years. This has led to the opioid epidemic in the US. This is an issue that Clearing focuses on with its digital healthcare platform that works to find new ways to treat chronic pain.
The system is used by patients who are able to describe their pain via the online platform, before Clearing’s clinicians customize a tailor-made treatment plan to meet the patient’s needs. This plan may include non-addictive supplements, topical creams, and personalized exercises via an app. The aim is to help to increase access to pain relief, which is nonaddictive and affordable.
Clearing is a new player in a digital health market that already has competition from more established companies targeting chronic pain, such as Hinge Health, AppliedVR, and Spine Zone. However, the company, that is considered a game changer for chronic pain sufferers, will be able to scale operations after raising $20 million in seed funding, helping secure its goal of removing barriers to quality, personalised pain treatment.
Kirsty
Company Specialist at Welcome to the Jungle
May 2021
$20m
SEED
Sep 2020
$4m
SEED
This company has top investors
Jacob Hascalovici
(Chief Medical Officer)Former Clinical Assistant Professor at Albert Einstein College of Medicine prior to co-founding Clearing.
Yakov Kagan
(Head of Growth)They have extensive experience in product and growth. They are also the Advisor at Salvo Health.
Avi Dorfman
(CEO)Founded Compass and Salvo Health, where they are serving as the Lead Board Member for the latter. They are also an Angel Investor.